TCI Wealth Advisors’s LYRA THERAPEUTICS INC LYRA Stock Holding History

TCI Wealth Advisors’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1	Closed	–	–	1603
2020 Q3	$0	Buy	+1	New	+$622	﹤0.01%	1602

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

TCI Wealth Advisors's LYRA Position: Q4 2020 in Review

TCI Wealth Advisors sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2020, closing a stake of 1 share.

TCI Wealth Advisors first reported a position in LYRA in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 43 funds tracked by Wall St. Rank hold LYRA as of Q4 2020.

TCI Wealth Advisors reported no remaining LYRA THERAPEUTICS INC position as of Q4 2020 after selling out during the quarter.
TCI Wealth Advisors sold 1 LYRA THERAPEUTICS INC share in Q4 2020.
TCI Wealth Advisors first reported a position in LYRA THERAPEUTICS INC in Q3 2020 and held it in 1 quarter.
TCI Wealth Advisors's LYRA THERAPEUTICS INC position peaked at $0 in Q3 2020.
43 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2020.

Based on TCI Wealth Advisors's 13F filing for Q4 2020, filed 21 Jan 2021.